Ben Wolf will lead this complimentary webinar about then-Secretary of the Department of Health and Human Services Alex Azar’s Public Health Emergency (PHE) declared in January 2020. This triggered the FDA’s Emergency Use Authorization authority and over the ensuing months, the FDA has employed its authority and policies of enforcement discretion to ensure that adequate medical products are available to Americans.
COVID-19 continues to infect many people in the U.S. every day, but the FDA has contemplated the impact of the end of pandemic regulations on medical products. Topics for EUA holders and those with medical products on the market under policies of enforcement discretion include:
- FDA’s transition plans related to the end of the PHE
- Practical tips to manage the transition
- What companies can do now to prepare
- Ben Wolf, Senior Associate, Alston & Bird
This program is provided as a complimentary service to clients and friends of Alston & Bird. CLE credit is pending for Georgia and South Carolina. Additional states may be available upon request.
To register, or for more information, contact Jacob Greifinger at email@example.com or at 404.881.7907.